16
Joslin Diabetes Center Advances in Diabetes and Thyroid Disease 2013 Diabetes and Sleep Copyright © 2013 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any distribution or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Joslin Diabetes Center is prohibited. Diabetes and sleep Robert Joseph Thomas, M.D. November 9, 2013 [email protected] Conflict No conflict of relevance to this presentation Recent reviews Tahrani AA, Ali A, Stevens MJ. Obstructive sleep apnea and diabetes: an update. Curr Opin Pulm Med 2013;19:631-8. Mesarwi O, Polak J, Jun J, Polotsky VY. Sleep disorders and the development of insulin resistance and obesity. Endocrinol Metab Clin North Am 2013;42:617-34. 1

Slides 27 Diabetes Sleep - Joslin Diabetes Center · PDF file1.00-1.18) and DM (OR: 1.14, CI: 1.03-1.25) • Adjusted for BMI, gender, physical activity, coronary artery disease, night

Embed Size (px)

Citation preview

Page 1: Slides 27 Diabetes Sleep - Joslin Diabetes Center · PDF file1.00-1.18) and DM (OR: 1.14, CI: 1.03-1.25) • Adjusted for BMI, gender, physical activity, coronary artery disease, night

Joslin Diabetes CenterAdvances in Diabetes and Thyroid Disease 2013Diabetes and Sleep

Copyright © 2013 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any distribution or reuse of this presentation or any part of it in any form for other than personal use without the express writtenpermission of Joslin Diabetes Center is prohibited.

Diabetes and sleep

Robert Joseph Thomas, M.D.

November 9, 2013

[email protected]

Conflict

• No conflict of relevance to this presentation

Recent reviews

Tahrani AA, Ali A, Stevens MJ. Obstructive sleep apnea and diabetes: an update. Curr Opin Pulm Med 2013;19:631-8.

Mesarwi O, Polak J, Jun J, Polotsky VY. Sleep disorders and the development of insulin resistance and obesity. Endocrinol Metab Clin North Am 2013;42:617-34.

1

Page 2: Slides 27 Diabetes Sleep - Joslin Diabetes Center · PDF file1.00-1.18) and DM (OR: 1.14, CI: 1.03-1.25) • Adjusted for BMI, gender, physical activity, coronary artery disease, night

Joslin Diabetes CenterAdvances in Diabetes and Thyroid Disease 2013Diabetes and Sleep

Copyright © 2013 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any distribution or reuse of this presentation or any part of it in any form for other than personal use without the express writtenpermission of Joslin Diabetes Center is prohibited.

Sleep restriction

• Obesity and increased caloric intake

• Change in food preference

• Glucose intolerance

• Sympathetic activity increases

• Affective impact

• Executive impact

Sleep restriction and metabolome(Physiol Behav 2013;122C:25-31 [Bell])

• 11 subjects with Type II diabetes in parents, 6M/5F; age: 26 ±3 years; BMI 23.5±2.3 Kg/M2

• Two 8-night inpatient sessions with restricted (5.5) vs. adequate (8.5-h) time-in-bed sleep opportunity

• Two UHPLC/MS/MS and one GC/MS platform was used to measure metabolites in fasting plasma samples

• Relative concentrations of 12 amino acids were increased when sleep was curtailed

• Elevations in several fatty acid, bile acid, steroid hormone, and tricarboxylic acid cycle intermediates

Intermittent hypoxia effects(Sleep 2013;36:1483-90 [Polak])

• C57BL6/J mice were exposed to 14 days of IH, 14 days of intermittent air, or 7 days of IH followed by 7 days of intermittent air (recovery paradigm)

• IH increased fasting glucose levels and worsened glucose tolerance by 67% and 27%, respectively

• Impaired insulin sensitivity / beta cell function, increase in liver glycogen, higher hepatocyte glucose output, and an increase in oxidative stress in the pancreas

• While fasting glucose levels and hepatic glucose output normalized after discontinuation of the hypoxic exposure, glucose intolerance, insulin resistance, and impairments in beta cell function persisted

2

Page 3: Slides 27 Diabetes Sleep - Joslin Diabetes Center · PDF file1.00-1.18) and DM (OR: 1.14, CI: 1.03-1.25) • Adjusted for BMI, gender, physical activity, coronary artery disease, night

Joslin Diabetes CenterAdvances in Diabetes and Thyroid Disease 2013Diabetes and Sleep

Copyright © 2013 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any distribution or reuse of this presentation or any part of it in any form for other than personal use without the express writtenpermission of Joslin Diabetes Center is prohibited.

Audience response question

• Does sleep apnea cause congestive heart failure?

– Yes (1)

– No (2)

– Need more information (3)

Sleep apnea and IHD CHF(Circulation 2011;123:1280-6)

• Sleep Heart Health Study

• 1927 men and 2495 women > or =40 years of age and free of coronary heart disease and heart failure

• Followed up for a median of 8.7 years

• OSA a significant predictor of incident IHD only in men < or =70 years of age (adjusted HR 1.10 [95% CI 1.00 to 1.21] per 10-unit increase in AHI (not in women)

• OSA predicted incident heart failure in men but not in women (adjusted HR 1.13 [95% CI 1.02 to 1.26] per 10-unit increase in AHI).

• Men with AHI > or =30 were 58% more likely for CHF

Why is the risk from sleep apnea “not much” or “needs a lot”?

• Aha! Ischemic preconditioning!

• (Sleep Breath 2012, in Press, First Author: Shah)

• 136 acute MI

• 35 % had an AHI >5

• Higher AHI was associated with lower peak troponin-T levels (p = 0.0085) (“adjusted for everything”)

• This makes clinical sense

• Most with profoundly severe sleep apnea wake up the next say and get on with it

• Does not mean apnea is “good for you”…..

3

Page 4: Slides 27 Diabetes Sleep - Joslin Diabetes Center · PDF file1.00-1.18) and DM (OR: 1.14, CI: 1.03-1.25) • Adjusted for BMI, gender, physical activity, coronary artery disease, night

Joslin Diabetes CenterAdvances in Diabetes and Thyroid Disease 2013Diabetes and Sleep

Copyright © 2013 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any distribution or reuse of this presentation or any part of it in any form for other than personal use without the express writtenpermission of Joslin Diabetes Center is prohibited.

Audience response question

• Does pathological sleep cause dysglycemia or diabetes?

– Yes (1)

– No (2)

– Need more information (3)

Respirology 2012 (Wang, E-pub)Sleep apnea causing diabetes

• Meta-analysis of six prospective cohort studies, 5,953 participants

• Follow-up periods of 2.7-16 years

• 332 incident cases of type 2 diabetes

• Moderate-severe OSA was associated with a greater risk of diabetes [relative risk (RR) 1.63; 95% confidence interval (CI) 1.09-2.45], as compared with the absence of OSA.

J Clin Endocrinol Metab 2012 (Myhill, E-pub)No quick fix

• Fremantle Diabetes Study Phase II

• 59 at high risk for OSA

• Randomized to a 3-month CPAP intervention initiated early (<1 week) or late (1-2 months).

• Data were pooled

• Improved: sleepiness, blood pressure, resting heart rate

• Unchanged: Glycemic control and serum lipids

4

Page 5: Slides 27 Diabetes Sleep - Joslin Diabetes Center · PDF file1.00-1.18) and DM (OR: 1.14, CI: 1.03-1.25) • Adjusted for BMI, gender, physical activity, coronary artery disease, night

Joslin Diabetes CenterAdvances in Diabetes and Thyroid Disease 2013Diabetes and Sleep

Copyright © 2013 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any distribution or reuse of this presentation or any part of it in any form for other than personal use without the express writtenpermission of Joslin Diabetes Center is prohibited.

Sleep 2012; 35(9):1293-1298 (Rice)Sleep apnea causing problems in diabetics

• Sub-study of Look AHEAD (Sleep AHEAD)

• 350 diabetics, 86% had OSA (AHI > 5)

• The AHI was associated with stroke with an adjusted odds ratio (95% confidence interval) of 2.57 (1.03, 6.42).

• Not with heart disease in this small cohort

N Engl J Med 2011;365:2277-86 (Sharma)CPAP for extreme sleep apnea + metabolic

syndrome

• Double-blind, placebo-controlled trial

• OSA, 3 months CPAP / sham, flip after a month

• 86 patients completed the study, 75 (87%) of whom had the metabolic syndrome

• CPAP: significant decreases in SBP (3.9 mm Hg), DBP (2.5 mm Hg), serum total cholesterol (13.3 mg / dL), LCL-C (9.6 mg per deciliter; 95% CI, 2.5 to 16.7; P=0.008), triglycerides (18.7 mg / dL), and HbA1c (0.2%)

• MS reversal: 11/86 real, 1/86 sham

• Enrolled 90! Perfect CPAP use! Unrealistic in real life

• Extreme sleep apnea (AHI > 50, severe desaturations)

Diabetes Care 2012; (Pamidi, E-pub)Sleep apnea impact on lean diabetics

• Prospective, 52 healthy men (age 18-30 years; BMI 18-25 Kg/M2

• Polysomnogram + OGTT

• Matched, 20 control men without OSA and 12 men with OSA

• OSA had 27% lower insulin sensitivity (estimated by Matsuda index) and 37% higher total insulin secretion (AUC) than the control subjects, despite comparable glucose levels.

5

Page 6: Slides 27 Diabetes Sleep - Joslin Diabetes Center · PDF file1.00-1.18) and DM (OR: 1.14, CI: 1.03-1.25) • Adjusted for BMI, gender, physical activity, coronary artery disease, night

Joslin Diabetes CenterAdvances in Diabetes and Thyroid Disease 2013Diabetes and Sleep

Copyright © 2013 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any distribution or reuse of this presentation or any part of it in any form for other than personal use without the express writtenpermission of Joslin Diabetes Center is prohibited.

Diabetes Care 2012;35:1902-1906 (Priou)Sleep apnea and HbA1c in non-diabetics

• HbA1c data in 1599 patients, PSG

• Dose-response relationship was observed between AHI and the percentage of patients with HbA1c >6.0%

• Range: from 10.8% for AHI <5 to 34.2% for AHI ≥50.

• Statistical adjustment for age, sex, smoking habits, BMI, waist circumference, cardiovascular morbidity, daytime sleepiness, depression, insomnia, sleep duration.

• Odds ratios (95% CIs) for HbA1c >6.0% were 1 (reference), 1.40 (0.84-2.32), 1.80 (1.19-2.72), 2.02 (1.31-3.14), and 2.96 (1.58-5.54) for AHI values <5, 5 to <15, 15 to <30, 30 to <50, and ≥50, respectively.

Diabetologia 2010; ;53(3):481-8 (Muraki)Nocturnal hypoxia and incident diabetes risk

• Circulatory Risk in Communities Study (CIRCS)

• 4,398 community residents aged 40 to 69 years

• Nocturnal hypoxia by pulse-oximetry, 2001-2005

• ODI3 < 5, 5-15 (mild), or greater

• By the end of 2007, 92.2% of participants had been followed up 3.0 [2.9-4.0] years), 210 persons identified as having developed diabetes.

• The multivariable-adjusted hazard ratio (95% CI) for developing type 2 diabetes was 1.26 (0.91-1.76) and 1.69 (1.04-2.76) for mild / greater hypoxia

Sleep 2012;35:617-625 (Weinstock)CPAP improves glycemic control only if….

• 50 subjects, AHI > 15, impaired glucose tolerance

• 8 weeks of CPAP or sham CPAP, flip after 1 month

• 2-hour OGTT

• 42% men, age 54± 10, BMI of 39 ±8, and AHI 44 ±27

• Seven subjects normalized their mean 2-h OGTT after CPAP but not after sham CPAP, while 5 subjects normalized after sham CPAP but not after CPAP

• No overall insulin sensitivity index improvement

• AHI ≥ 30 (n = 25): 13.3% (p < 0.001) improvement in ISI (0,120) and 28.7% (95%CI: [-46.5%, -10.9%], P = 0.002) reduction in the 2-h insulin level

6

Page 7: Slides 27 Diabetes Sleep - Joslin Diabetes Center · PDF file1.00-1.18) and DM (OR: 1.14, CI: 1.03-1.25) • Adjusted for BMI, gender, physical activity, coronary artery disease, night

Joslin Diabetes CenterAdvances in Diabetes and Thyroid Disease 2013Diabetes and Sleep

Copyright © 2013 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any distribution or reuse of this presentation or any part of it in any form for other than personal use without the express writtenpermission of Joslin Diabetes Center is prohibited.

Long naps and diabetes risk(Sleep Med 2013;14:950-4 [Fang])

• 27,009 participants, four groups according to nap duration (no napping, <30, 30 to <60, 60 to <90, and ⩾90 minutes)

• 18,515 (68.6%) reported regularly taking afternoon naps

• Those with longer (90 minutes) nap duration had considerably higher prevalence of IFG (OR: 1.09 (CI: 1.00-1.18) and DM (OR: 1.14, CI: 1.03-1.25)

• Adjusted for BMI, gender, physical activity, coronary artery disease, night sleep duration, alcohol, hypertension…...

Mediators of sleep pathology

• Deprivation

• Fragmentation

• Hypoxia

• Hemodynamics

• Inflammation

• Vascular function

• Metabolic function

• Neurogenesis (hippocampal)

• Gene-environmental interaction: apoε4

Sleep Hypnogram

Normal Young Adult

OSA->Fragmentation

7

Page 8: Slides 27 Diabetes Sleep - Joslin Diabetes Center · PDF file1.00-1.18) and DM (OR: 1.14, CI: 1.03-1.25) • Adjusted for BMI, gender, physical activity, coronary artery disease, night

Joslin Diabetes CenterAdvances in Diabetes and Thyroid Disease 2013Diabetes and Sleep

Copyright © 2013 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any distribution or reuse of this presentation or any part of it in any form for other than personal use without the express writtenpermission of Joslin Diabetes Center is prohibited.

Fragmented sleep

Consolidated sleep

8

Page 9: Slides 27 Diabetes Sleep - Joslin Diabetes Center · PDF file1.00-1.18) and DM (OR: 1.14, CI: 1.03-1.25) • Adjusted for BMI, gender, physical activity, coronary artery disease, night

Joslin Diabetes CenterAdvances in Diabetes and Thyroid Disease 2013Diabetes and Sleep

Copyright © 2013 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any distribution or reuse of this presentation or any part of it in any form for other than personal use without the express writtenpermission of Joslin Diabetes Center is prohibited.

Sympathetic Activation and OSA

Shamsuzzaman ASM, Gersh BJ, Somers VK. JAMA 2003;290:1906-1914.

Audience Response Question

• Does sleep apnea cause hypertension?

– Yes

– No

– Need more clinical human data

– Need more experimental data

Does sleep apnea cause hypertension?

• Yes– Longitudinal data (Sleep Heart Health Study, etc)

• Effects on blood pressure– Nocturnal– Daytime

• Mediators (dominant)– Hypoxia for daytime– Fragmentation for nocturnal

• Time scales– Hypoxia has very complex time scales of effects– Carotid bodies important– Increased sympathetic drive

9

Page 10: Slides 27 Diabetes Sleep - Joslin Diabetes Center · PDF file1.00-1.18) and DM (OR: 1.14, CI: 1.03-1.25) • Adjusted for BMI, gender, physical activity, coronary artery disease, night

Joslin Diabetes CenterAdvances in Diabetes and Thyroid Disease 2013Diabetes and Sleep

Copyright © 2013 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any distribution or reuse of this presentation or any part of it in any form for other than personal use without the express writtenpermission of Joslin Diabetes Center is prohibited.

Audience response question

• Does sleep apnea cause stroke?

– Yes (1)

– No (2)

– Need more information (3)

Stroke

• Bidirectional interactions

• Sleep apnea causes stroke – Acute stroke: nearly universal, at least half “resolve”

• Sleep apnea causes stroke– Best data from SHHS

– Needs plenty of sleep apnea

• Sleep apnea in stroke patients is often “mixed” and hard to treat

• Possible stroke recurrence risk

Sleep apnea and stroke(Am J Respir Crit Care Med 2010;182:269-77)

• Sleep Heart health Study

• Baseline PSG between 1995 and 1998

• 5,422 without stroke at the baseline

• Median follow-up 8.7 years, 193 ischemic strokes

• Men in the highest AHI quartile (>19) had an adjusted hazard ratio of 2.86 (95% confidence interval, 1.1-7.4).

• In the AHI range 5-25, each one-unit increase in AHI in men was estimated to increase stroke risk by 6% (95% confidence interval, 2-10%).

• In women, stroke risk only increased with AHI > 25.

10

Page 11: Slides 27 Diabetes Sleep - Joslin Diabetes Center · PDF file1.00-1.18) and DM (OR: 1.14, CI: 1.03-1.25) • Adjusted for BMI, gender, physical activity, coronary artery disease, night

Joslin Diabetes CenterAdvances in Diabetes and Thyroid Disease 2013Diabetes and Sleep

Copyright © 2013 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any distribution or reuse of this presentation or any part of it in any form for other than personal use without the express writtenpermission of Joslin Diabetes Center is prohibited.

Glucose metabolism and sleep

• Deprivation, restriction, fragmentation, hypoxia and circadian mismatch leads to dysmetabolism and increased insulin resistance

• Sleep apnea extremely common in obese type II diabetics

• Treatment trials have been generally disappointing– Seems only really severe apnea (e.g., AHI ≥ 30 / hour) clearly

matters

• Likely responsive and unresponsive phenotypes

Atrial fibrillation

• Complex interactions

• More common in OSA

• Strong association in hypertrophic cardiomyopathy

• Strong CSA association with idiopathic central sleep apnea syndrome– Suggests chemoreflex activation is important

• Increase in recurrence risk with untreated sleep apnea

• Nocturnal triggering is almost always sleep apnea

• No coherent clinical approach advocated, in part due to sheer numbers to deal with

Atrial fibrillation – sleep apneaHeart Rhythm 2013;10(3):331-7

• “Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: Clinical impact of continuous positive airway pressure therapy”

• 153 patients (128 men; 60±9 years)

• Extensive encircling pulmonary vein isolation for drug refractory AF.

• 116 patients were identified as having OSA

• Mean follow-up period of 18.8±10.3 months, 51 (33%) patients experienced AF recurrences after ablation

• A Cox regression analysis: LA volume (HR 1.11; 95% CI 1.01-1.23; concomitant OSA (HR 2.61; 95% CI 1.12-6.09), usage of CPAP therapy (HR 0.41; 95% CI 0.22-0.76;) were associated with AF recurrences.

11

Page 12: Slides 27 Diabetes Sleep - Joslin Diabetes Center · PDF file1.00-1.18) and DM (OR: 1.14, CI: 1.03-1.25) • Adjusted for BMI, gender, physical activity, coronary artery disease, night

Joslin Diabetes CenterAdvances in Diabetes and Thyroid Disease 2013Diabetes and Sleep

Copyright © 2013 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any distribution or reuse of this presentation or any part of it in any form for other than personal use without the express writtenpermission of Joslin Diabetes Center is prohibited.

Sleep in aging and Alzheimer’s disease

• Sleep fragmentation– Macro-fragmentation

– Micro-fragmentation

– Standard stages not too useful as vast majority of sleep in elderly is “light, stage II”

• Sleep apnea– Role in subcortical white matter injury

• Circadian dysregulation

• Depression

• High risk conditions for increased afferent sensory input– Pain, drugs

– Motor disorders and disability

– Heart failure, dyspnea

Sleep and beta amyloid

• Sleep restriction and fragmentation increase Aβ

• Hypoxia increases Aβ

• Hypoxia reduces Aβ clearance

• Sleep enables junk washout from brain interstitium

• Sleep apnea increases incident MCI/AD diagnosis risk (Study of Osteoporosis Fractures; SOF)

Sleep and vascular dementia

• Data from Korean Genome and Epidemiology Study and Framingham Heart Study

12

Page 13: Slides 27 Diabetes Sleep - Joslin Diabetes Center · PDF file1.00-1.18) and DM (OR: 1.14, CI: 1.03-1.25) • Adjusted for BMI, gender, physical activity, coronary artery disease, night

Joslin Diabetes CenterAdvances in Diabetes and Thyroid Disease 2013Diabetes and Sleep

Copyright © 2013 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any distribution or reuse of this presentation or any part of it in any form for other than personal use without the express writtenpermission of Joslin Diabetes Center is prohibited.

So…..

• Hypertension

• Diabetes

• Congestive heart failure

• Atrial fibrillation

• Stroke

• Dementia

What can you do

• It seems that everyone has sleep apnea!

• Everyone with diabetes gets a eye exam– Routine now but is a parallel medical industry in its own right

• So why not a sleep physiology / pathology assessment?

• Oximetry is cheap, practical and a good screen-in

• Once screened, then comes the “problem”

• Sleep management is complex, time intensive, expensive, requires substantial ongoing patient effort

• Mildly symptomatic individuals will find this burdensome

• It needs a parallel system run from within the diabetes centers

Some nuts and bolts

• Several insurance specific issues– A real pain, time sink

• Home testing vs. lab testing– Former reasonable for uncomplicated sleep apnea

• Lab titration vs. auto-CPAP– Key is to track clinical and device based outcomes

– Onerous compliance / adherence requirements

• Current devices track useful respiratory parameters

13

Page 14: Slides 27 Diabetes Sleep - Joslin Diabetes Center · PDF file1.00-1.18) and DM (OR: 1.14, CI: 1.03-1.25) • Adjusted for BMI, gender, physical activity, coronary artery disease, night

Joslin Diabetes CenterAdvances in Diabetes and Thyroid Disease 2013Diabetes and Sleep

Copyright © 2013 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any distribution or reuse of this presentation or any part of it in any form for other than personal use without the express writtenpermission of Joslin Diabetes Center is prohibited.

40

Normal Sleepiness

3 pm 9 pm 3 am 9 am

AsleepAwake

SLEEP

9 am

Circadian Drive for Wakefulness

Sleep Drive

The circadian system

WORKWake Propensity

Must read for circadian-metabolism link

• Bass J. Circadian topology of metabolism. Nature 2012;491:348-56.

• Peek CB, Ramsey KM, Marcheva B, Bass J. Nutrient sensing and the circadian clock. Trends Endocrinol Metab 2012;23:312-8.

The circadian system

• Sleep effects more intuitive

• Profound whole body effects

• Much of new research focused on clock mechanisms outside sleep-wake regulation

• Circadian dysregulation effects (experimental models)

– Metabolic syndrome

– Hypertension

– Vascular dysfunction

– Cardiac failure

– Renal failure

14

Page 15: Slides 27 Diabetes Sleep - Joslin Diabetes Center · PDF file1.00-1.18) and DM (OR: 1.14, CI: 1.03-1.25) • Adjusted for BMI, gender, physical activity, coronary artery disease, night

Joslin Diabetes CenterAdvances in Diabetes and Thyroid Disease 2013Diabetes and Sleep

Copyright © 2013 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any distribution or reuse of this presentation or any part of it in any form for other than personal use without the express writtenpermission of Joslin Diabetes Center is prohibited.

Diabetes and the circadian system

• Nothing good in shift work for diabetics

• Circadian disruption accelerates diabetes development in human islet amyloid polypeptide transgenic (HIP) rats

• Increased risk for incident diabetes in shift workers?– Obesity major confounder

• More metabolic syndrome in former night-shift workers

• Food intake is misaligned – dysglycemic, dysmetabolic

• Using bright light, consistent schedules and perhaps hypnotics could help

Shift work and diabetes risk(J Biol Rhythms 2013;28:356-9 [Monk])

• Telephone survey: 1111 retired adults (≥65 years; 634 male, 477 female)

• Five shift work exposure bins were considered: 0 years, 1-7 years, 8-14 years, 15-20 years, and >20 years.

• Shift work exposed groups showed an increased proportion of self-reported diabetes, OR about 2

• The effect remained significant after adjusting for gender and BMI

Summary

• Sleep management needs to be integrated into cardiometabolic management

• Challenges of cost effectiveness, administrative burden

• Point-Of-Care testing and treatment

15

Page 16: Slides 27 Diabetes Sleep - Joslin Diabetes Center · PDF file1.00-1.18) and DM (OR: 1.14, CI: 1.03-1.25) • Adjusted for BMI, gender, physical activity, coronary artery disease, night

Joslin Diabetes CenterAdvances in Diabetes and Thyroid Disease 2013Diabetes and Sleep

Copyright © 2013 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any distribution or reuse of this presentation or any part of it in any form for other than personal use without the express writtenpermission of Joslin Diabetes Center is prohibited.

Thank you

[email protected]

16